858 Therapeutics

United States
Wonewoc, Wisconsin, United States, 92121

Company profile

858 Therapeutics company profile

858 Therapeutics is a biotechnology company focused on discovering small molecule therapeutics for novel targets in oncology and immunology. The company emphasizes innovative approaches in synthetic lethality, innate immunity, and RNA modulation. Its lead program is a PARG inhibitor currently in early clinical development.

Business identity

Contact email
[email protected]
Phone number
(858) 987-8380
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
92121
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$130.1M
Last funding
Series B / $50M / 2024-09-26
Last equity funding
Series B / $50M
Investors
8
Lead investors
2
Founders
3
Articles
31

Founders and investors

Founders

Gretchen BainJeffrey StaffordJim Veal

Lead investors

Avidity PartnersVersant Ventures

Investors

Alexandria Venture InvestmentsCormorant Asset ManagementInsight PartnersNew Enterprise AssociatesVersant Ventures